The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe post-operative pain
Lichtor JL, Sevarino FB, Joshi GP, Busch MA, Nordbrock E, Ginsberg B. The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe post-operative pain. Anesth Analg 1999; 89: 732-38.
Oral transmucosal fentanyl citrate: A randomised, double-blind, placebo-controlled trial for the treatment of breakthrough pain in cancer patients
Farrar JT, Cleary J, Busch MA, Nordbrock E. Oral transmucosal fentanyl citrate: a randomised, double-blind, placebo-controlled trial for the treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998; 90: 611-16.
Dose titration multicentre study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain
Christie JM, Simmonds M, Patt R, et al. Dose titration multicentre study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain. J Clin Oncol 1998; 16: 3238-45.
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: A controlled dose titration study
Portenoy RK, Payne R, Coluzzi P, et al. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study. Pain 1999; 79: 303-12.